封面
市场调查报告书
商品编码
1621747

家禽诊断市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Poultry Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年,全球家禽诊断市场价值为 7.025 亿美元,预计 2024 年至 2032 年复合年增长率为 10.5%。这些工具利用分子诊断和血清学测试等技术,帮助识别病原体并监测鸡群健康状况,解决禽流感和沙门氏菌病等疾病。有效的诊断对于疾病控制、生物安全和家禽养殖的经济稳定发挥着至关重要的作用。这一市场成长的主要驱动力是人们日益认识到家禽疾病对食品安全和公共卫生的影响。

全球更严格的法规旨在提高家禽健康标准,从而扩大使用诊断工具进行早期疾病识别和预防。这些工具对于早期检测禽流感、新城疫和沙门氏菌等疾病至关重要,以便及时采取干预措施,以防止疫情爆发。市场分为组成部分,主要是产品和服务。该产品细分市场到2023年占60.4%的市场份额,进一步分为试剂盒和试剂以及设备和仪器。

诊断试剂盒和试剂等产品因其成本效益和可及性而广受欢迎,使农民能够透过最少的培训来监测鸡群健康状况。快速检测试剂盒可快速提供结果,特别有益,使农民能够即时管理鸡群健康并防止疾病升级。就技术而言,市场分为PCR检测、ELISA检测等。 ELISA 检测在检测多种家禽病原体方面具有高灵敏度和特异性,到 2023 年价值将达到 4.032 亿美元,在该领域占据主导地位。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 7.025 亿美元
预测值 17亿美元
复合年增长率 10.5%

ELISA 的快速结果和最新的技术进步使其成为寻求可靠诊断的家禽生产商的首选。从疾病角度来看,市场包括禽流感、新城疫、禽沙门氏菌病等。禽流感部分预计在预测期内将以 10.8% 的速度成长。由于其传染性以及对家禽和人群的影响,禽流感的早期检测和控制变得至关重要,从而推动了诊断投资。

家禽诊断的最终用户包括兽医院和诊所、家禽养殖场和诊断实验室。 2023年,由于家禽疾病的日益普及以及对确保准确疾病检测的专业诊断服务的需求,兽医院和诊所的价值达到3.238亿美元。在美国,家禽诊断市场 2023 年价值 2.578 亿美元,预计到 2032 年将达到 6.168 亿美元

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 增加家禽消费
      • 家禽健康意识不断增强
      • 人畜共患病发生率上升
    • 产业陷阱与挑战
      • 发展中地区获得先进技术的机会有限
  • 成长潜力分析
  • 监管环境
  • 未来市场趋势
  • 定价分析
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按组成部分,2021 - 2032 年

  • 主要趋势
  • 产品
    • 试剂盒和试剂
    • 设备仪器
  • 服务
    • 临床化学
    • 分子诊断
    • 血清学
    • 细菌学
    • 病毒学
    • 寄生虫学
    • 其他服务

第 6 章:市场估计与预测:按技术分类,2021 - 2032 年

  • 主要趋势
  • 酵素连结免疫吸附试验
  • PCR检测
  • 其他技术

第 7 章:市场估计与预测:按疾病类型,2021 - 2032

  • 主要趋势
  • 禽流感
  • 禽沙门氏菌病
  • 新城疫
  • 禽支原体疾病
  • 传染性支气管炎
  • 传染性法氏囊病
  • 禽巴氏桿菌病
  • 禽脑脊髓炎
  • 禽呼肠孤病毒
  • 鸡贫血
  • 其他疾病

第 8 章:市场估计与预测:按最终用途,2021 - 2032 年

  • 主要趋势
  • 兽医医院和诊所
  • 家禽养殖场
  • 诊断实验室

第 9 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 10 章:公司简介

  • Affinitech
  • Agrobiotek Internacional
  • Agrolabo
  • Antech Diagnostics
  • BIOMERIEUX
  • Boehringer Ingelheim
  • Embark Veterinary
  • FUJIFILM Corporation
  • GD Animal Health
  • IDEXX Laboratories
  • IDvet
  • Innovative Diagnostics
  • Megacor Diagnostik
  • Thermo Fisher Scientific
  • Zoetis
简介目录
Product Code: 12072

The Global Poultry Diagnostics Market, valued at USD 702.5 million in 2023, is anticipated to grow at a CAGR of 10.5% from 2024 to 2032. Poultry diagnostics are essential tools and methods used to detect and manage diseases in birds raised for meat and eggs. Utilizing techniques like molecular diagnostics and serological tests, these tools help identify pathogens and monitor flock health, addressing diseases such as avian influenza and salmonellosis. Effective diagnostics play a crucial role in disease control, biosecurity, and the economic stability of poultry farming. A primary driver of this market growth is the increasing awareness of the impact of poultry diseases on food safety and public health.

Stricter regulations worldwide aim to enhance poultry health standards, resulting in the expanded use of diagnostic tools for early disease identification and prevention. Such tools are vital for detecting diseases like avian influenza, Newcastle disease, and Salmonella at early stages, allowing timely interventions to prevent outbreaks. The market is divided into components, primarily products and services. The product segment, which held a 60.4% market share in 2023, is further categorized into kits & reagents and equipment & instruments.

Products such as diagnostic kits and reagents are popular for their cost-effectiveness and accessibility, allowing farmers to monitor flock health with minimal training. Rapid test kits, providing quick results, are particularly beneficial, enabling farmers to manage flock health in real-time and prevent disease escalation. In terms of technology, the market is segmented into PCR tests, ELISA tests, and others. ELISA tests, valued at USD 403.2 million in 2023, dominate the segment due to their high sensitivity and specificity in detecting a wide array of poultry pathogens.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$702.5 Million
Forecast Value$1.7 Billion
CAGR10.5%

ELISA's rapid results and recent technological advancements make it a preferred option among poultry producers seeking reliable diagnostics. Disease-wise, the market includes avian influenza, Newcastle disease, avian salmonellosis, and others. The avian influenza segment is projected to grow at a rate of 10.8% over the forecast period. Due to its contagious nature and impact on both poultry and human populations, early detection and control of avian influenza have become critical, driving investment in diagnostics.

End users of poultry diagnostics include veterinary hospitals & clinics, poultry farms, and diagnostic laboratories. In 2023, the veterinary hospitals & clinics segment was valued at USD 323.8 million, driven by the growing prevalence of poultry diseases and the demand for specialized diagnostic services that ensure accurate disease detection. In the U.S., valued at USD 257.8 million in 2023, the poultry diagnostics market is expected to reach USD 616.8 million by 2032

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing poultry consumption
      • 3.2.1.2 Growing awareness of poultry health
      • 3.2.1.3 Rising incidence of zoonotic diseases
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Limited access to advanced technologies in developing regions
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Future market trends
  • 3.6 Pricing analysis
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Products
    • 5.2.1 Kits & reagents
    • 5.2.2 Equipment & instruments
  • 5.3 Services
    • 5.3.1 Clinical chemistry
    • 5.3.2 Molecular diagnostics
    • 5.3.3 Serology
    • 5.3.4 Bacteriology
    • 5.3.5 Virology
    • 5.3.6 Parasitology
    • 5.3.7 Other services

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 ELISA tests
  • 6.3 PCR test
  • 6.4 Other technologies

Chapter 7 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Avian influenza
  • 7.3 Avian salmonellosis
  • 7.4 Newcastle disease
  • 7.5 Avian mycoplasmosis
  • 7.6 Infectious bronchitis
  • 7.7 Infectious bursal disease
  • 7.8 Avian pasteurellosis
  • 7.9 Avian encephalomyelitis
  • 7.10 Avian reovirus
  • 7.11 Chicken anemia
  • 7.12 Other diseases

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Veterinary hospitals & clinics
  • 8.3 Poultry farms
  • 8.4 Diagnostic laboratories

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Affinitech
  • 10.2 Agrobiotek Internacional
  • 10.3 Agrolabo
  • 10.4 Antech Diagnostics
  • 10.5 BIOMERIEUX
  • 10.6 Boehringer Ingelheim
  • 10.7 Embark Veterinary
  • 10.8 FUJIFILM Corporation
  • 10.9 GD Animal Health
  • 10.10 IDEXX Laboratories
  • 10.11 IDvet
  • 10.12 Innovative Diagnostics
  • 10.13 Megacor Diagnostik
  • 10.14 Thermo Fisher Scientific
  • 10.15 Zoetis